Join
Live feed
·
INSIDERFilingvia Quantisnow
Pulse Biosciences Inc logo

Director Zanganeh Mahkam converted options into 60,242 shares, increasing direct ownership by 10% to 665,153 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PLSE· Pulse Biosciences Inc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PLSE (Pulse Biosciences Inc) and more on Quantisnow.